Synbiotic Supplementation and Inflammation in Predialysis Chronic Kidney Disease
Starting soon · Not applicable · Has a placebo group
Conditions studied: Chronic Kidney Disease, Inflammation
In brief
Chronic kidney disease (CKD) is a long-term condition in which the kidneys gradually lose their ability to function properly. People with chronic kidney disease (CKD) often experience chronic inflammation and digestive symptoms that may affect their quality of life. This study aims to evaluate whether daily supplementation with a synbiotic (a combination of probiotics and prebiotics) can reduce inflammation and improve gastrointestinal symptoms in adults with chronic kidney disease (CKD) stages 3 to 5 who are not receiving dialysis. Participants will be randomly assigned to receive either a synbiotic containing Lactobacillus rhamnosus, Bifidobacterium longum, and agave fructans, or a placebo, for a total of 16 weeks. Blood tests will be performed to measure inflammation, and participants will complete questionnaires related to digestive symptoms, quality of life, and dietary habits. The information obtained from this study may help improve nutritional strategies and supportive care for people living with chronic kidney disease.
Key facts
- Study ID
- NCT07430280
- Run by
- Centenario Hospital Miguel Hidalgo
- People needed
- 100
- Starts
- 2026-03-01
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2026-02-27
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged 18 to 80 years.
- Diagnosis of chronic kidney disease in pre-dialysis stages.
- Stable clinical condition for at least 3 months prior to enrollment.
- Ability to provide written informed consent.
You may not qualify if…
- Current renal replacement therapy (hemodialysis or peritoneal dialysis).
- Acute kidney injury.
- Use of antibiotics, probiotics, prebiotics, or synbiotics within 4 weeks prior to enrollment.
- Active infection, inflammatory disease, or malignancy.
- Pregnancy or breastfeeding
- Known intolerance or allergy to components of the synbiotic or placebo.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.